Ad is loading...
MPZSX
Price
$10.04
Change
-$0.06 (-0.59%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MPZSX vs RNWFX

Header iconMPZSX vs RNWFX Comparison
Open Charts MPZSX vs RNWFXBanner chart's image
MassMutual Strat Emerg Mkts I
Price$10.04
Change-$0.06 (-0.59%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
MPZSX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MPZSX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPZSX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. MPZSX (98.4M). RNWFX pays higher dividends than MPZSX: RNWFX (1.51) vs MPZSX (0.12). MPZSX was incepted earlier than RNWFX: MPZSX (14 years) vs RNWFX (23 years). MPZSX is a more actively managed with annual turnover of: 38.00 vs. RNWFX (32.00). MPZSX has a lower initial minimum investment than RNWFX: MPZSX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. MPZSX (4.71). RNWFX return over 5 years is better than : 17.17 vs. MPZSX (-25.79).
MPZSXRNWFXMPZSX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD0.3007.0994%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets98.4M60.9B0%
Annual Yield % from dividends0.121.518%
Returns for 1 year4.7111.5441%
Returns for 3 years-35.05-14.55241%
Returns for 5 years-25.7917.17-150%
Returns for 10 years-10.3841.00-25%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics